COVID-19 BioResource

Working with committed and passionate researchers and participants, we are involved in coronavirus cutting edge research

At the emergence of the Coronavirus pandemic at the turn of 2020, our teams explored how we might contribute.

The COVID BioResource was the response by our network and our partners, using our unique expertise in sample handling and our participant contributions to drive research into the genetics of COVID.

There's a short video about human genetics and COVID on the GenOMICC site.

Studies are well under way and some have already been completed.  We have already made a significant contribution to the international effort in this field.


We are recruiting four groups of people to the COVID BioResource.

  • those who have been diagnosed with COVID and have been admitted to hospital, both in the wards and in the Intensive Care Units (ICU). 
  • those who have been diagnosed with COVID but have mild symptoms
  • those who have been diagnosed with COVID but are asymptomatic (apparently no symptoms)
  • those who are being or have been vaccinated

We are also interested in people joining the BioResource who have not been diagnosed with COVID.

Our researchers have done a lot of very successful work following the phenotyping of patients over time and severity of disease.  We are also keen to monitor vaccination responses.

If you are interested in taking part please see our Participants section for further information or contact us

Want to make a difference?

If you join us, you are helping to speed the progress of medical research. Every one of us makes a difference


Studies have already had a significant number of papers published and you can view them on our publications page


If you are a researcher interested in COVID research see our section on Applying for NIHR BioResource support  and our COVID specific application form.

GenOMICC study

We are a key partner in the GenOMICC study - a major new human whole genome sequencing study taking place across the UK National Health Service.

Currently, the genomes of people (currently or previously in an intensive care unit with coronavirus and those who have mild or moderate symptoms) are being analysed.

The ultimate aim is to develop a full catalogue of human genetic variation and COVID by recruiting every single COVID-19 patient who admitted to intensive care in the UK.